Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and non-prescription drugs. Its operations are carried out through the following segments: Medicine, Non-Prescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs. The Non-Prescription Drugs segment offers over-the-counter (OTC) drugs, quasi drugs and health food products. The Special Sales segment deals with the manufacture and sale of pharmaceutical raw materials, export products, intermediate products, and other products for pharmaceutical companies. The Others segment includes real estate leasing business. The company was founded in April 1929 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company